Exports were happening on humanitarian grounds but with necessary permission
Trump has touted the antimalarial as a treatment for the coronavirus since the early weeks of the global outbreak, calling it a "game-changer," but its prospects have faded
This is because while emergency-use authorisation for treating Covid-19 was a recent move, the drug has been used since years for rheumatoid arthritis and lupus
In the new set of protocols, the ministry has removed its earlier recommendation of using hydroxychloroquine in combination with azithromycin in severe cases
The pandemic debate is all divided by ideology and top BJP leaders are exploiting a grave crisis in cynical political self-interest. The result looks like nobody is in control
Why was the trial of the drug on Dharavi residents put on hold? What prompted the authorities to restart? What connection does the coming US election have with all this?
Here's a selection of Business Standard opinion pieces of the day.
About 90% of the global mortality was in the northerly latitudes, above roughly 30 degrees north
Once touted as a 'wonder drug', HCQ has been battling global controversies around its safety and efficacy as a prophylactic against the new coronavirus SARS-CoV-2.
From patients struggling to find hospital beds, to the crisis moving to India's rural areas, and what a new study says about hydroxychloroquine - read these and more in today's India dispatch
Based on this development, we can no longer vouch for the veracity of the primary data sources, the retraction statement noted
HCQ was dropped from the solidarity trial that WHO was conducting as a part of a global effort in May.
Almost 90 per cent of the participants, according to the study, reported a high-risk exposure to a confirmed Covid-19 contact
From how Prince Charles 'got away lightly', to cheap beach holidays targetting locals, and why Africa has to weather the storm without massive stimulus - read these and more in today's world dispatch
Hydroxychloroquine did not seem to cause serious harm but was no better than placebo pills, says medical journal.
The World Health Organization said Wednesday that it will resume recruiting patients for the hydroxychloroquine arm of a global trial called Solidarity.
According to the National Task Force for Covid-19 in India recommended once a week maintenance dose for seven weeks (400 mg once weekly), following the loading dose (400 mg bd)
A spokeswoman for Mandeep R Mehra, the Harvard professor who was the paper's lead author, said on Friday that the study's authors had asked for an independent academic review and audit of their work.
It also stated that the decision of WHO to temporarily suspend quality HCQ trials based on findings of the Lancet study appears to be a "knee-jerk reaction"
They must be worn and taken off properly to ensure any contaminated surfaces don't touch the face, and if reusable, washed regularly